simple tube thoracostomy versus surgery in pleural infection management

simple tube thoracostomy versus surgical debridement in complicated parapneumonic empyema management

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20170504033818N2

Enrollment

104

Registered

2018-07-27

Start date

2003-08-23

Completion date

Unknown

Last updated

2018-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: empyema. Condition 2: empyema after pneumonia. Condition 3: pleural effusion. Condition 4: empyema without fistula. Pyothorax Pneumonia, unspecified Pleural effusion, not elsewhere classified Pyothorax without fistula

Interventions

Intervention 1: The intervention group are treated by a simple Tube Thoracostomy . Intervention 2: The control group are prepared for surgery and undergo debridement for draining empyema and inserting

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: suffering from empyema - that has been proved using pleural fluid aspiration - due to the fluid accumulation following pneumonia undergoing the second phase of the empyema

Exclusion criteria

Exclusion criteria: impossibility of anesthesia due to the associated conditions that increases the risk of surgical treatment the presence of bronchopleural fistula empyema with multiple loculations that is not treated only using the chest tube. empyema in the first or third phase empyema after surgery or trauma

Design outcomes

Primary

Measure	Time frame
Complications after discharge. Timepoint: one week and one month. Method of measurement: Fever, respiratory distress and difficulty in breathing.;Duration of each treatment procedure. Timepoint: from the beginning of the patient’s admission to the end of the medication taking. Method of measurement: the number of the recorded days.	—

Secondary

Measure	Time frame
Recurrence after recovery. Timepoint: one week and one month after discharge. Method of measurement: signs , symptoms and paraclinical results.;The duration of hospitalization. Timepoint: The date of admission to patient discharge. Method of measurement: the number of the recorded days.;The duration of having chest tube. Timepoint: From the chest tube insertion to its removal. Method of measurement: the number of the recorded days.;Duration of each treatment procedure. Timepoint: from the beginning of the patient’s admission to the end of the medication taking. Method of measurement: the number of the recorded days.	—

Measure

Time frame

Recurrence after recovery. Timepoint: one week and one month after discharge. Method of measurement: signs , symptoms and paraclinical results.;The duration of hospitalization. Timepoint: The date of admission to patient discharge. Method of measurement: the number of the recorded days.;The duration of having chest tube. Timepoint: From the chest tube insertion to its removal. Method of measurement: the number of the recorded days.;Duration of each treatment procedure. Timepoint: from the beginning of the patient’s admission to the end of the medication taking. Method of measurement: the number of the recorded days.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactShima jafari jebeli

Islamic Azad University Najafabad Branch

shimajafari8998@gmail.com+98 31 3627 2001

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026